Bayer AG
BAYRYOTCHealthcare● Active
$10.15
$-0.15(-1.43%)
Market Cap$39.9B
P/E Ratio—
52W High$14.85
52W Low$7.19
Bayer AG（BAYRY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BAYRY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($3.48B) | ($2.55B) | ($2.94B) | $4.17B | $1.02B |
| Depreciation & Amort. | $3.89B | $8.78B | $3.93B | $6.50B | $3.06B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.36B | $0.24B |
| Change in Working Capital | $5.91B | $0.09B | ($4.07B) | ($2.70B) | $1.06B |
| Net Cash from Operations | $4.39B | $7.37B | $5.12B | $7.09B | $5.09B |
| Investing Activities | |||||
| Capital Expenditure | ($2.39B) | ($2.78B) | ($2.75B) | ($2.95B) | ($2.61B) |
| Purchases of Investments | ($0.17B) | ($0.25B) | ($0.45B) | ($3.01B) | ($0.40B) |
| Sales of Investments | $0.81B | $2.58B | $0.14B | $0.03B | $4.70B |
| Net Cash from Investing | ($1.55B) | $0.16B | ($4.01B) | ($2.38B) | $0.85B |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.01B) | ($0.02B) | ($0.02B) | $0.00B | $0.00B |
| Dividends Paid | ($0.12B) | ($0.13B) | ($2.38B) | ($1.97B) | ($1.96B) |
| Debt Issued / Repaid | ($2.04B) | ($5.02B) | $3.25B | ($0.97B) | ($2.45B) |
| Net Cash from Financing | ($2.10B) | ($7.18B) | ($0.68B) | ($4.22B) | ($5.64B) |
| Free Cash Flow | |||||
| Free Cash Flow | $2.00B | $4.59B | $2.37B | $4.14B | $2.48B |
| FCF Margin %(computed) | 4.57% | 9.85% | 4.97% | 8.17% | 5.62% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解Bayer AG
关于Bayer AG（BAYRY）现金流量表
Bayer AG 2025财年经营活动现金流$4.39B，自由现金流$2.00B（FCF利润率4.57%），资本支出($2.39B)。
常见问题
BAYRY · 4 问Bayer AG 2025财年自由现金流$2.00B，同比down56.4%。
BAYRY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10